Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04892732 · ClinicalTrials.gov registry record
Replication of the D58 Asthma Trial in Healthcare Claims Data
A clinical trial of Asthma, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 66,581
- Enrollment target
- 1
- Study location
NCT04892732: Completed study of Asthma, sponsored by Brigham and Women's Hospital.
NCT04892732 is a study of Asthma that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 66,581 participants, above the 1,385-participant average among 374 other Asthma trials with a reported enrollment target (4707% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04892732, a study of Asthma, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 66,581 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Primary Outcome
A composite of adjudicated death, intubation, and hospitalization
Conditions Studied
Interventions
- DRUG Budesonide
- DRUG Budesonide-Formoterol
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66,581 participants |
| Start Date | 2020-10-29 |
| Est. Completion | 2021-06-11 |
What the finished NCT04892732 record still lists
NCT04892732 is an observational study that tracks outcomes without assigning an intervention. Its 66,581 participants enrollment target places it among the larger protocols in the corpus, above the 1,385-participant average among 374 other Asthma trials with a reported enrollment target (4707% higher).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Budesonide is the first listed.
NCT04892732 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04892732 about?
NCT04892732 is a clinical study titled "Replication of the D58 Asthma Trial in Healthcare Claims Data". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...
What is the current status of trial NCT04892732?
This trial is currently completed. The enrollment target is 66,581 participants. The study started on 2020-10-29. Estimated completion is 2021-06-11.
What conditions does trial NCT04892732 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT04892732?
The interventions under investigation include: Budesonide (DRUG), Budesonide-Formoterol (DRUG).
Who is sponsoring clinical trial NCT04892732?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04892732 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04892732's enrollment target sits among peer trials
66,581 2nd of 374 the highest of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00009633 · 68,000 participants
Follow-up Visit of High Risk Infants
- NCT06903897 · 68,000 participants · NA
Social Needs Screening and Chronic Diseases Study (WE CARE)
- NCT04473833 · 65,000 participants · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- NCT05128006 · 63,200 participants
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI